Careers
Contact Us

Company
Pipeline
Disease States
Science
Investors

Axsome Therapeutics Initiates MOMENTUM Phase 3 Trial of AXS-07 in Migraine

Posted March 4, 2019 by CognitionDev

filed under: Nasdaq

In the News

Oct 2, 2019

Axsome Therapeutics to Provide Update on Continued Progress at the 2019 Cantor Global Healthcare Conference

Click to view full release

Sep 5, 2019

Axsome Therapeutics Presents Positive AXS-07 Phase 1 Trial Results at the 19th Congress of the International Headache Society

Click to view full release

Sep 3, 2019

Axsome Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

Click to view full release

See All News

© 2019 Axsome Therapeutics, Inc. All rights reserved. 200 Broadway, 3rd Floor, New York, NY 10038 info@axsome.com

This modal has no inner div